PAK3 mutations responsible for severe intellectual disability and callosal agenesis inhibit cell migration.
Agenesis of Corpus Callosum
/ complications
Amino Acid Sequence
Animals
COS Cells
Cell Movement
/ physiology
Child
Chlorocebus aethiops
HEK293 Cells
Humans
Intellectual Disability
/ complications
Male
Mutation
/ genetics
Pedigree
Protein Structure, Secondary
Severity of Illness Index
p21-Activated Kinases
/ chemistry
Cell adhesion
Cell migration
Cell spreading
Corpus callosum agenesis (CCA)
Intellectual disability
Kinase
Neurodevelopmental disorder
PAK3
αPIX/ARHGEF6
Journal
Neurobiology of disease
ISSN: 1095-953X
Titre abrégé: Neurobiol Dis
Pays: United States
ID NLM: 9500169
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
09
05
2019
revised:
13
11
2019
accepted:
08
12
2019
pubmed:
18
12
2019
medline:
5
1
2021
entrez:
18
12
2019
Statut:
ppublish
Résumé
Corpus callosum agenesis (CCA) is a brain malformation associated with a wide clinical spectrum including intellectual disability (ID) and an etiopathological complexity. We identified a novel missense G424R mutation in the X-linked p21-activated kinase 3 (PAK3) gene in a boy presenting with severe ID, microcephaly and CCA and his fetal sibling with CCA and severe hydrocephaly. PAK3 kinase is known to control synaptic plasticity and dendritic spine dynamics but its implication is less characterized in brain ontogenesis. In order to identify developmental functions of PAK3 impacted by mutations responsible for CCA, we compared the biochemical and biological effects of three PAK3 mutations localized in the catalytic domain. These mutations include two "severe" G424R and K389N variants (responsible for severe ID and CCA) and the "mild" A365E variant (responsible for nonsyndromic mild ID). Whereas they suppressed kinase activity, only the two severe variants displayed normal protein stability. Furthermore, they increased interactions between PAK3 and the guanine exchange factor αPIX/ARHGEF6, disturbed adhesion point dynamics and cell spreading, and severely impacted cell migration. Our findings highlight new molecular defects associated with mutations responsible for severe clinical phenotypes with developmental brain defects.
Identifiants
pubmed: 31843706
pii: S0969-9961(19)30384-5
doi: 10.1016/j.nbd.2019.104709
pii:
doi:
Substances chimiques
PAK3 protein, human
EC 2.7.11.1
p21-Activated Kinases
EC 2.7.11.1
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
104709Informations de copyright
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.